author-photo

S. P. Chawla

CytRx

58

Papers

1225

Citations

Citation Trend

Filter By

Papers (35) Sort By

Journal Conference Others

458PSafety, efficacy, PK and PD biomarker results of the first-in-human study of mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor BAY 1436032 in patients (pts) with mIDH1 advanced solid tumours

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Phase III study of aldoxorubicin vs investigators' choice as treatment for relapsed/refractory soft tissue sarcomas.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (25)
Administration of aldoxorubicin and 14 days continuous infusion of ifosfamide/mesna in metastatic or locally advanced sarcomas.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
1480PDA phase 2 study of CMB305 and atezolizumab in NY-ESO-1+ soft tissue sarcoma: Interim analysis of immunogenicity, tumor control and survival

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Efficacy and safety of tamibarotene or placebo added to paclitaxel/carboplatin for advanced non-small cell lung cancer.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A phase 1/2 study of continuous infusion ifosfamide/mesna + aldoxorubicin in sarcoma patients.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Phase 2 study of aldoxorubicin in relapsed glioblastoma.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072

2016 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (25)
Randomized phase 3, multicenter, open-label study comparing evofosfamide (Evo) in combination with doxorubicin (D) vs. D alone in patients (pts) with advanced soft tissue sarcoma (STS): Study TH-CR-406/SARC021

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (13)
Long-term results of a randomized phase II study of trabectedin by two different dose and schedule regimens in patients with advanced liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)